Pharmaron shareholders plan significant share reduction

Pharmaron Beijing (SZSE:300759) announced that two shareholders, Shenzhen Zhongkang Investment Partnership (LP) and Shenzhen Zhonglong Investment Partnership (LP), plan to reduce their holdings. Shenzhen Zhongkang Investment Partnership, which currently holds 12.57% of total share capital, intends to sell up to 0.50%. Shenzhen Zhonglong Investment Partnership, holding 1.60%, plans to sell up to 1%.

The share reductions, totaling up to 1.50% of total share capital, will occur within three months, starting 15 trading days after the announcement's disclosure (December 8, 2025). The sales will be executed through centralized bidding or block trades on the Shenzhen Stock Exchange. The shareholders cited the expiration of their partnership agreements and their own capital needs as reasons for the reduction.

The company stated that the planned reduction is a normal shareholder action and is not expected to significantly affect Pharmaron Beijing's corporate governance structure, equity structure, or ongoing operations. The share prices for the reduction will be determined by secondary market prices but will not be below the company's initial public offering price.